Anthony Quinn, EVP, CMO, & Head of R&D at Synageva, holds 161.33K shares in Generation Bio (Ticker: GBIO), holds 816.84K shares in Spyre Therapeutics (Ticker: SYRE), holds 31.60K shares in Kaleido Biosciences (Ticker: KLDO). Most recently, Anthony Quinn Bought ― shares of Generation Bio on Dec 05, 2023 for an estimated value of 124.78K.
What is the percentage of profitable transactions made by Anthony Quinn?
The percentage of profitable transactions made by Anthony Quinn is 78%.
What is the average return per transaction made by Anthony Quinn?
The average return per transaction made by Anthony Quinn is 5.90%.
What stocks does Anthony Quinn hold?
Anthony Quinn holds: GEVA, SYRE, KLDO, GBIO stocks.
What was Anthony Quinn’s latest transaction?
Anthony Quinn latest transaction was an Informative Buy of $124.78K.
What was Anthony Quinn's most profitable transaction?
Anthony Quinn’s most profitable transaction was an Informative Buy of SYRE stock on December 5, 2017. The return on the trade was 71.00%.
What is Anthony Quinn's role in Synageva?
Anthony Quinn's role in Synageva is EVP, CMO, & Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.